Seeing Is Believing
APVO is currently covered by 1 analysts with an average price target of $62583.57. This is a potential upside of $62580.32 (1925548.31%) from yesterday's end of day stock price of $3.25.
Aptevo Therapeutics's activity chart (see below) currently has 7 price targets and 19 ratings on display. The stock rating distribution of APVO is 100% BUY.
Highest price target for APVO is $7, Lowest price target is $7.
Most recent stock forecast was given by JONATHAN ASCHOFF from ROTH on 23-Sep-2024. First documented stock forecast 05-Oct-2017.
Currently out of the existing stock ratings of APVO, 1 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
9 months ago
(23-Sep-2024)
0/2 (0%)
$38876.64 (91.42%)
Buy
2 years 10 months 11 days ago
(12-Aug-2022)
0/3 (0%)
$86284 (331.25%)
What is APVO (Aptevo Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on APVO (Aptevo Therapeutics) with a proven track record?
Which analyst has the current lower performing score on APVO (Aptevo Therapeutics) with a proven track record?
Which analyst has the most public recommendations on APVO (Aptevo Therapeutics)?
Which analyst is the currently most bullish on APVO (Aptevo Therapeutics)?
Which analyst is the currently most reserved on APVO (Aptevo Therapeutics)?